DC HEALTHCARE RECORDS 65% SURGE IN PROFIT BEFORE TAX FOR Q2FY2023

Group’s Focus on Aesthetic Medical Services Continues to Drive Success, With Plans for Further Expansion in Northern and Southern Regions of Peninsular Malaysia

KUALA LUMPUR, 29 AUGUST 2023 – DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, announced its financial performance for the current financial quarter ended 30 June 2023. The Group achieved a 6.43% quarter-on-quarter revenue increase, totalling RM17.89 million. Aesthetic services continue to be the primary driver, contributing 89.00% to the total revenue.

The Group's profit before tax marked a substantial growth of 65%, amounting to RM5.27 million, compared to RM3.19 million in the previous quarter. This growth illustrates DC Healthcare's effectiveness in leveraging revenue increases to generate significant profit. The overall profit after tax (PAT) for the current period is RM4.02 million, with the year-to-date PAT reaching RM6.37 million.

In line with these successes, the Group's ongoing expansion strategy is further solidifying its market presence. Dr. Chong Tze Sheng, Managing Director of DC Healthcare, stated, “The addition of 2 new clinics in the first half of the year, bringing our total to 13 clinics and as well as the increase in the number of treatments provided, has played a vital role in driving this growth. It not only reflects our commitment to increasing access to our services but also emphasizes our belief in the quality of care we provide.

With the Malaysian aesthetic medicine market projected to register a CAGR of 18.8% from 2021 to 2027, our prospects in the aesthetic medical service industry remain favourable. Our planned expansion in the Southern and Northern regions, coupled with investments in technology and skilled personnel, underlines our confidence in our competitive strengths and the favourable industry outlook.”

For the financial period-to-date ended 30 June 2023, the Group's total revenue stands at RM34.70 million, and a profit before tax of RM8.46 million.

Moving forward, DC Healthcare’s strategy continues to focus on its core business. The Group plans to expand existing clinics, strengthen medical staff, and continuously upgrade technology to support the growth in the aesthetic medicine market.

As at 29 August 2023, the share price of DC Healthcare stands at RM0.51 sen per share, reflecting a market capitalisation of RM513.1 million.